130 related articles for article (PubMed ID: 20364278)
21. Biological and clinical implications of HBV infection in peripheral blood mononuclear cells.
Pontisso P; Vidalino L; Quarta S; Gatta A
Autoimmun Rev; 2008 Oct; 8(1):13-7. PubMed ID: 18706529
[TBL] [Abstract][Full Text] [Related]
22. Inhibitory effect of HMGN2 protein on human hepatitis B virus expression and replication in the HepG2.2.15 cell line.
Feng Y; He F; Zhang P; Wu Q; Huang N; Tang H; Kong X; Li Y; Lu J; Chen Q; Wang B
Antiviral Res; 2009 Mar; 81(3):277-82. PubMed ID: 19150374
[TBL] [Abstract][Full Text] [Related]
23. Small hepatitis B surface antigen interacts with and modulates enoyl-coenzyme A hydratase expression in hepatoma cells.
Gong X; Zhu Y; Dong J; Chen J; You J; Zheng Q; Rao Z; Mao Q; Jiang J
Arch Virol; 2013 May; 158(5):1065-70. PubMed ID: 23275097
[TBL] [Abstract][Full Text] [Related]
24. Presentation of the hydrophilic domains of hepatitis C viral E2 envelope glycoprotein on hepatitis B surface antigen particles.
Lee IH; Kim CH; Ryu WS
J Med Virol; 1996 Oct; 50(2):145-51. PubMed ID: 8915880
[TBL] [Abstract][Full Text] [Related]
25. Role of surface promoter mutations in hepatitis B surface antigen production and secretion in occult hepatitis B virus infection.
Sengupta S; Rehman S; Durgapal H; Acharya SK; Panda SK
J Med Virol; 2007 Mar; 79(3):220-8. PubMed ID: 17245717
[TBL] [Abstract][Full Text] [Related]
26. Modulation of the outcome and severity of hepadnaviral hepatitis in woodchucks by antibodies to hepatic asialoglycoprotein receptor.
Diao J; Slaney DM; Michalak TI
Hepatology; 2003 Sep; 38(3):629-38. PubMed ID: 12939589
[TBL] [Abstract][Full Text] [Related]
27. Hepatitis B virus Dane particles bind to human plasma apolipoprotein H.
Stefas I; Rucheton M; D'Angeac AD; Morel-Baccard C; Seigneurin JM; Zarski JP; Martin M; Cerutti M; Bossy JP; Missé D; Graafland H; Veas F
Hepatology; 2001 Jan; 33(1):207-17. PubMed ID: 11124838
[TBL] [Abstract][Full Text] [Related]
28. Osthole increases glycosylation of hepatitis B surface antigen and suppresses the secretion of hepatitis B virus in vitro.
Huang RL; Chen CC; Huang YL; Hsieh DJ; Hu CP; Chen CF; Chang C
Hepatology; 1996 Sep; 24(3):508-15. PubMed ID: 8781315
[TBL] [Abstract][Full Text] [Related]
29. The mannose receptor acts as hepatitis B virus surface antigen receptor mediating interaction with intrahepatic dendritic cells.
Op den Brouw ML; Binda RS; Geijtenbeek TB; Janssen HL; Woltman AM
Virology; 2009 Oct; 393(1):84-90. PubMed ID: 19683778
[TBL] [Abstract][Full Text] [Related]
30. Virus-induced anti-asialoglycoprotein receptor autoimmunity in experimental hepadnaviral hepatitis.
Diao J; Michalak TI
Hepatology; 1997 Mar; 25(3):689-96. PubMed ID: 9049220
[TBL] [Abstract][Full Text] [Related]
31. Specific targeted binding of herpes simplex virus type 1 to hepatocytes via the human hepatitis B virus preS1 peptide.
Argnani R; Boccafogli L; Marconi PC; Manservigi R
Gene Ther; 2004 Jul; 11(13):1087-98. PubMed ID: 15057264
[TBL] [Abstract][Full Text] [Related]
32. High expression of beta2-glycoprotein I is associated significantly with the earliest stages of hepatitis B virus infection.
Liu YM; Zhang WY; Wang ZF; Yan CY; Gao PJ
J Med Virol; 2014 Aug; 86(8):1296-306. PubMed ID: 24760738
[TBL] [Abstract][Full Text] [Related]
33. Myristoylated PreS1-domain of the hepatitis B virus L-protein mediates specific binding to differentiated hepatocytes.
Meier A; Mehrle S; Weiss TS; Mier W; Urban S
Hepatology; 2013 Jul; 58(1):31-42. PubMed ID: 23213046
[TBL] [Abstract][Full Text] [Related]
34. Efficient inhibition of hepatitis B virus infection by acylated peptides derived from the large viral surface protein.
Gripon P; Cannie I; Urban S
J Virol; 2005 Feb; 79(3):1613-22. PubMed ID: 15650187
[TBL] [Abstract][Full Text] [Related]
35. Liver-derived cell lines QSG-7701 and HepG2 support different HBV replication patterns.
Pan XB; Wei L; Chen HS; Liu F; Gao Y
Arch Virol; 2007; 152(6):1159-73. PubMed ID: 17308979
[TBL] [Abstract][Full Text] [Related]
36. Stable inhibition of hepatitis B virus proteins by small interfering RNA expressed from viral vectors.
Moore MD; McGarvey MJ; Russell RA; Cullen BR; McClure MO
J Gene Med; 2005 Jul; 7(7):918-25. PubMed ID: 15756649
[TBL] [Abstract][Full Text] [Related]
37. Identification and characterization of peptides that interact with hepatitis B virus via the putative receptor binding site.
Deng Q; Zhai JW; Michel ML; Zhang J; Qin J; Kong YY; Zhang XX; Budkowska A; Tiollais P; Wang Y; Xie YH
J Virol; 2007 Apr; 81(8):4244-54. PubMed ID: 17192308
[TBL] [Abstract][Full Text] [Related]
38. Human bone marrow mesenchymal stem cells are resistant to HBV infection during differentiation into hepatocytes in vivo and in vitro.
Xie C; Zheng YB; Zhu HP; Peng L; Gao ZL
Cell Biol Int; 2009 Apr; 33(4):493-500. PubMed ID: 19272332
[TBL] [Abstract][Full Text] [Related]
39. Mechanisms of co-modified liver-targeting liposomes as gene delivery carriers based on cellular uptake and antigens inhibition effect.
Zhang Y; Rong Qi X; Gao Y; Wei L; Maitani Y; Nagai T
J Control Release; 2007 Feb; 117(2):281-90. PubMed ID: 17196291
[TBL] [Abstract][Full Text] [Related]
40. [Effect of cell cycle on telomerase activity of hepatoma cells and its relationship with replication of hepatitis B virus].
Yan SN; Deng B; Gong ZJ
Ai Zheng; 2003 May; 22(5):504-7. PubMed ID: 12753712
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
